1au1: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
New page: left|200px<br /> <applet load="1au1" size="450" color="white" frame="true" align="right" spinBox="true" caption="1au1, resolution 2.2Å" /> '''HUMAN INTERFERON-BET...
 
No edit summary
Line 1: Line 1:
[[Image:1au1.gif|left|200px]]<br />
[[Image:1au1.gif|left|200px]]<br /><applet load="1au1" size="350" color="white" frame="true" align="right" spinBox="true"  
<applet load="1au1" size="450" color="white" frame="true" align="right" spinBox="true"  
caption="1au1, resolution 2.2&Aring;" />
caption="1au1, resolution 2.2&Aring;" />
'''HUMAN INTERFERON-BETA CRYSTAL STRUCTURE'''<br />
'''HUMAN INTERFERON-BETA CRYSTAL STRUCTURE'''<br />


==Overview==
==Overview==
Type I interferons (IFNs) are helical cytokines that have diverse, biological activities despite the fact that they appear to interact with, the same receptor system. To achieve a better understanding of the, structural basis for the different activities of alpha and beta IFNs, we, have determined the crystal structure of glycosylated human IFN-beta at, 2.2-A resolution by molecular replacement. The molecule adopts a fold, similar to that of the previously determined structures of murine IFN-beta, and human IFN-alpha2b but displays several distinct structural features., Like human IFN-alpha2b, human IFN-beta contains a zinc-binding site at the, interface of the two molecules in the asymmetric unit, raising the, question of functional relevance for IFN-beta dimers. However, unlike the, human IFN-alpha2b dimer, in which homologous surfaces form the interface, human IFN-beta dimerizes with contact surfaces from opposite sides of the, molecule. The relevance of the structure to the effects of point mutations, in IFN-beta at specific exposed residues is discussed. A potential role of, ligand-ligand interactions in the conformational assembly of IFN receptor, components is discussed.
Type I interferons (IFNs) are helical cytokines that have diverse biological activities despite the fact that they appear to interact with the same receptor system. To achieve a better understanding of the structural basis for the different activities of alpha and beta IFNs, we have determined the crystal structure of glycosylated human IFN-beta at 2.2-A resolution by molecular replacement. The molecule adopts a fold similar to that of the previously determined structures of murine IFN-beta and human IFN-alpha2b but displays several distinct structural features. Like human IFN-alpha2b, human IFN-beta contains a zinc-binding site at the interface of the two molecules in the asymmetric unit, raising the question of functional relevance for IFN-beta dimers. However, unlike the human IFN-alpha2b dimer, in which homologous surfaces form the interface, human IFN-beta dimerizes with contact surfaces from opposite sides of the molecule. The relevance of the structure to the effects of point mutations in IFN-beta at specific exposed residues is discussed. A potential role of ligand-ligand interactions in the conformational assembly of IFN receptor components is discussed.


==Disease==
==Disease==
Line 11: Line 10:


==About this Structure==
==About this Structure==
1AU1 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with ZN as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1AU1 OCA].  
1AU1 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=ZN:'>ZN</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1AU1 OCA].  


==Reference==
==Reference==
Line 26: Line 25:
[[Category: interferon]]
[[Category: interferon]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 16:01:49 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 11:48:17 2008''

Revision as of 12:48, 21 February 2008

File:1au1.gif


1au1, resolution 2.2Å

Drag the structure with the mouse to rotate

HUMAN INTERFERON-BETA CRYSTAL STRUCTURE

OverviewOverview

Type I interferons (IFNs) are helical cytokines that have diverse biological activities despite the fact that they appear to interact with the same receptor system. To achieve a better understanding of the structural basis for the different activities of alpha and beta IFNs, we have determined the crystal structure of glycosylated human IFN-beta at 2.2-A resolution by molecular replacement. The molecule adopts a fold similar to that of the previously determined structures of murine IFN-beta and human IFN-alpha2b but displays several distinct structural features. Like human IFN-alpha2b, human IFN-beta contains a zinc-binding site at the interface of the two molecules in the asymmetric unit, raising the question of functional relevance for IFN-beta dimers. However, unlike the human IFN-alpha2b dimer, in which homologous surfaces form the interface, human IFN-beta dimerizes with contact surfaces from opposite sides of the molecule. The relevance of the structure to the effects of point mutations in IFN-beta at specific exposed residues is discussed. A potential role of ligand-ligand interactions in the conformational assembly of IFN receptor components is discussed.

DiseaseDisease

Known diseases associated with this structure: Kaposi sarcoma, susceptibility to OMIM:[147620], Osteopenia/osteoporosis OMIM:[147620]

About this StructureAbout this Structure

1AU1 is a Single protein structure of sequence from Homo sapiens with as ligand. Full crystallographic information is available from OCA.

ReferenceReference

The crystal structure of human interferon beta at 2.2-A resolution., Karpusas M, Nolte M, Benton CB, Meier W, Lipscomb WN, Goelz S, Proc Natl Acad Sci U S A. 1997 Oct 28;94(22):11813-8. PMID:9342320

Page seeded by OCA on Thu Feb 21 11:48:17 2008

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA